221 related articles for article (PubMed ID: 16513623)
41. [123I]Mtr-TOCA, a radioiodinated and carbohydrated analogue of octreotide: scintigraphic comparison with [111In]octreotide.
Stahl A; Meisetschläger G; Schottelius M; Bruus-Jensen K; Wolf I; Scheidhauer K; Schwaiger M
Eur J Nucl Med Mol Imaging; 2006 Jan; 33(1):45-52. PubMed ID: 16151771
[TBL] [Abstract][Full Text] [Related]
42. Reduction of skeletal accumulation of radioactivity by co-injection of DTPA in [90Y-DOTA0,Tyr3]octreotide solutions containing free 90Y3+.
Breeman WA; De Jong MT; De Blois E; Bernard BF; De Jong M; Krenning EP
Nucl Med Biol; 2004 Aug; 31(6):821-4. PubMed ID: 15246375
[TBL] [Abstract][Full Text] [Related]
43. Crucial role for somatostatin receptor subtype 2 in determining the uptake of [111In-DTPA-D-Phe1]octreotide in somatostatin receptor-positive organs.
Hofland LJ; Lamberts SW; van Hagen PM; Reubi JC; Schaeffer J; Waaijers M; van Koetsveld PM; Srinivasan A; Krenning EP; Breeman WA
J Nucl Med; 2003 Aug; 44(8):1315-21. PubMed ID: 12902423
[TBL] [Abstract][Full Text] [Related]
44. Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients.
Virgolini I; Szilvasi I; Kurtaran A; Angelberger P; Raderer M; Havlik E; Vorbeck F; Bischof C; Leimer M; Dorner G; Kletter K; Niederle B; Scheithauer W; Smith-Jones P
J Nucl Med; 1998 Nov; 39(11):1928-36. PubMed ID: 9829585
[TBL] [Abstract][Full Text] [Related]
45. Tyr3-octreotide and Tyr3-octreotate radiolabeled with 177Lu or 90Y: peptide receptor radionuclide therapy results in vitro.
Capello A; Krenning EP; Breeman WA; Bernard BF; Konijnenberg MW; de Jong M
Cancer Biother Radiopharm; 2003 Oct; 18(5):761-8. PubMed ID: 14629824
[TBL] [Abstract][Full Text] [Related]
46. New trends in peptide receptor radioligands.
Virgolini I; Traub T; Novotny C; Leimer M; Füger B; Li SR; Patri P; Pangerl T; Angelberger P; Raderer M; Andreae F; Kurtaran A; Dudczak R
Q J Nucl Med; 2001 Jun; 45(2):153-9. PubMed ID: 11476164
[TBL] [Abstract][Full Text] [Related]
47. The role of radioactive somatostatin and its analogues in the control of tumor growth.
Krenning EP; Valkema R; Kooij PP; Breeman WA; Bakker WH; de Herder WW; van Eijck CH; Kwekkeboom DJ; de Jong M; Jamar F; Pauwels S
Recent Results Cancer Res; 2000; 153():1-13. PubMed ID: 10626285
[TBL] [Abstract][Full Text] [Related]
48. Biodistribution of 177Lu-octreotate and 111In-minigastrin in female nude mice transplanted with human medullary thyroid carcinoma GOT2.
Dalmo J; Rudqvist N; Spetz J; Laverman P; Nilsson O; Ahlman H; Forssell-Aronsson E
Oncol Rep; 2012 Jan; 27(1):174-81. PubMed ID: 21993546
[TBL] [Abstract][Full Text] [Related]
49. Metformin Reduces Renal Uptake of Radiotracers and Protects Kidneys from Radiation-Induced Damage.
Xiong C; Yin D; Li J; Huang Q; Ravoori MK; Kundra V; Zhu H; Yang Z; Lu Y; Li C
Mol Pharm; 2019 Feb; 16(2):808-815. PubMed ID: 30608713
[TBL] [Abstract][Full Text] [Related]
50. Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide.
Maresca KP; Marquis JC; Hillier SM; Lu G; Femia FJ; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
Bioconjug Chem; 2010 Jun; 21(6):1032-42. PubMed ID: 20402463
[TBL] [Abstract][Full Text] [Related]
51. New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy.
Virgolini I; Traub T; Leimer M; Novotny C; Pangerl T; Ofluoglu S; Halvadjieva E; Smith-Jones P; Flores J; Li SR; Angelberger P; Havlik E; Andreae F; Raderer M; Kurtaran A; Niederle B; Dudczak R
Q J Nucl Med; 2000 Mar; 44(1):50-8. PubMed ID: 10932601
[TBL] [Abstract][Full Text] [Related]
52. Reducing renal uptake of 111In-DOTATOC: a comparison among various basic amino acids.
Lin YC; Hung GU; Luo TY; Tsai SC; Sun SS; Hsia CC; Chen SL; Lin WY
Ann Nucl Med; 2007 Jan; 21(1):79-83. PubMed ID: 17373340
[TBL] [Abstract][Full Text] [Related]
53. Radiation dose distribution in human kidneys by octreotides in peptide receptor radionuclide therapy.
Konijnenberg M; Melis M; Valkema R; Krenning E; de Jong M
J Nucl Med; 2007 Jan; 48(1):134-42. PubMed ID: 17204710
[TBL] [Abstract][Full Text] [Related]
54. Inhomogeneous localization of radioactivity in the human kidney after injection of [(111)In-DTPA]octreotide.
De Jong M; Valkema R; Van Gameren A; Van Boven H; Bex A; Van De Weyer EP; Burggraaf JD; Körner M; Reubi JC; Krenning EP
J Nucl Med; 2004 Jul; 45(7):1168-71. PubMed ID: 15235063
[TBL] [Abstract][Full Text] [Related]
55. Albumin-derived peptides efficiently reduce renal uptake of radiolabelled peptides.
Vegt E; Eek A; Oyen WJ; de Jong M; Gotthardt M; Boerman OC
Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):226-34. PubMed ID: 19722105
[TBL] [Abstract][Full Text] [Related]
56. Renal metabolism of 111In-DTPA-D-Phe1-octreotide in vivo.
Akizawa H; Arano Y; Uezono T; Ono M; Fujioka Y; Uehara T; Yokoyama A; Akaji K; Kiso Y; Koizumi M; Saji H
Bioconjug Chem; 1998; 9(6):662-70. PubMed ID: 9815158
[TBL] [Abstract][Full Text] [Related]
57. Internalization of radiolabelled [DTPA0]octreotide and [DOTA0,Tyr3]octreotide: peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy.
De Jong M; Bernard BF; De Bruin E; Van Gameren A; Bakker WH; Visser TJ; Mäcke HR; Krenning EP
Nucl Med Commun; 1998 Mar; 19(3):283-8. PubMed ID: 9625504
[TBL] [Abstract][Full Text] [Related]
58. Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide.
Paganelli G; Zoboli S; Cremonesi M; Bodei L; Ferrari M; Grana C; Bartolomei M; Orsi F; De Cicco C; Mäcke HR; Chinol M; de Braud F
Eur J Nucl Med; 2001 Apr; 28(4):426-34. PubMed ID: 11357492
[TBL] [Abstract][Full Text] [Related]
59. Somatostatin receptor subtype 2-mediated uptake of radiolabelled somatostatin analogues in the human kidney.
Rolleman EJ; Kooij PP; de Herder WW; Valkema R; Krenning EP; de Jong M
Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1854-60. PubMed ID: 17546456
[TBL] [Abstract][Full Text] [Related]
60. Melanoma targeting with DOTA-alpha-melanocyte-stimulating hormone analogs: structural parameters affecting tumor uptake and kidney uptake.
Froidevaux S; Calame-Christe M; Tanner H; Eberle AN
J Nucl Med; 2005 May; 46(5):887-95. PubMed ID: 15872364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
